CIBC Asset Management Inc

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2024		-0.03%	$0	0	-1,740,518	-100%		Q2 2024
3/31/2024	0.03%	+0.01%	$8.56M	1.74M	+593,224	+51.7%	$4.92	Q1 2024
12/31/2023	0.04%	+0.03%	$10.1M	1.15M	+820,587	+251%	$8.79	Q4 2023
9/30/2023	0.02%	+0%	$3.75M	327K	+93,701	+40.2%	$11.47	Q3 2023
6/30/2023	0.02%	+0%	$5.9M	233K	+6,338	+2.8%	$25.31	Q2 2023
3/31/2023	0.03%	-0.02%	$7.3M	227K	-185,169	-45%	$32.21	Q1 2023
12/31/2022	0.03%	-0.01%	$7.6M	412K	-89,332	-17.8%	$18.46	Q4 2022
9/30/2022	0.06%	+0.06%	$13.5M	501K	+501,169	NEW	$27.00	Q3 2022
6/30/2022		-0.03%	$0	0	-470,819	-100%		Q2 2022
3/31/2022	0.03%	0%	$9.18M	471K	-27,410	-5.5%	$19.50	Q1 2022
12/31/2021	0.03%	+0.03%	$8.13M	498K	+498,229	NEW	$16.32	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.